MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1055/s-0044-1793932

Медицинская библиотека · Arquivos de neuro-psiquiatria · 2024

Neurovascular complications of antiphospholipid syndrome: a narrative review.

Mendes George Nilton Nunes, Morais Alessandra Braga Cruz Guedes de, Gioia Laura Catherine, Jacquin Grégory, Poppe Alexandre Y, Soga Felipe Hideki, Andrade João Brainer Clares de

СтатьяОбзорПеревод в очереди

Аннотация

BACKGROUND

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by thrombosis, pregnancy complications, and other nonthrombotic manifestations in the presence of antiphospholipid antibodies. Neurovascular complications, including ischemic stroke, cerebral venous thrombosis and cognitive impairment, pose significant challenges in management.

OBJECTIVE

To comprehensively review relevant and updated clinical aspects of neurovascular manifestations of APS.

METHODS

We conducted a narrative review using the PubMed, EMBASE, and Cochrane Library databases with medical terms related to APS and its neurovascular manifestations. English-language studies, published between January 1, 2015, and March 2024, were included. Key publications outside this timeframe were also considered. Studies with higher levels of evidence, such as randomized controlled trials and meta-analyses, were prioritized for inclusion.

RESULTS

Stroke is a prevalent complication in APS, with arterial thrombosis being a predominant mechanism. Despite recent trials, direct oral anticoagulants (DOACs) have not shown superiority over vitamin K antagonists (VKAs) for secondary prevention in this population. Cerebral venous thrombosis (CVT), although rare, can also occur in APS, and while DOACs have shown promise as a treatment in a general population, caution is warranted due to potential harm. Cognitive impairment affects a considerable proportion of APS patients, with thrombotic and nonthrombotic mechanisms contributing to its pathophysiology. Future research should focus on optimal management strategies for cognitive impairment and the efficacy of anticoagulation and immunosuppression.

CONCLUSION

Understanding the complex interplay of neurovascular manifestations in APS is essential for guiding clinical decisions and improving patient outcomes. Despite advancements, some challenges remain in establishing effective preventive and treatment measures, highlighting the need for further research in this field.

Для цитирования: Mendes George Nilton Nunes, Morais Alessandra Braga Cruz Guedes de, Gioia Laura Catherine, Jacquin Grégory, Poppe Alexandre Y, Soga Felipe Hideki, Andrade João Brainer Clares de. Neurovascular complications of antiphospholipid syndrome: a narrative review.. Arquivos de neuro-psiquiatria. 2024. DOI: 10.1055/s-0044-1793932.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.